Salar Mousa: Effect of COVID-19 on Initiation of Antithrombotic Therapy Post-Stroke in Sweden
Salar Mousa, PHD Student at Örebro University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I am very excited to share our newly published study examining the effect of COVID-19 pandemic on the initiation of antithrombotic therapy after stroke in Sweden.
Published in Basic and Clinical Pharmacology and Toxicology.
I would like to sincerely thank my supervisors and co-authors from Örebro University, Uppsala University and Gothenburg University for their support and work on this project.”
Title: Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre- and Post–COVID-19 in Sweden—An Interrupted Time Series Study
Authors: Salar Mousa, Katarina Persson, Maria Palmetun-Ekbäck, Fredrik Nyberg, Huiqi Li, Björn Wettermark, Mohammad Hossein Hajiebrahimi
Read the Full Article on Basic and Clinical Pharmacology and Toxicology
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis